Monosit/ Yüksek Dansiteli Lipoprotein (MHR) ve COVID-19 Arasındaki İlişkinin Değerlendirilmesi
Authors:
- Belgin CoşkunBCBelgin Coşkun
- Müge AyhanMAMüge Ayhan
- Elif Mukime SaricaoğluESElif Mukime Saricaoğlu
- Rahmet GünerRGRahmet Güner
- Esragül AkinciEAEsragül Akinci
- Turan BuzganTBTuran Buzgan
- Bircan KayaaslanBKBircan Kayaaslan
- Adalet AypakAAAdalet Aypak
- Ayşe Yasemin TEZER TEKÇEATAyşe Yasemin TEZER TEKÇE
- İmran HasanoğluIHİmran Hasanoğlu
- Ayşe KAYA KALEMAKAyşe KAYA KALEM
- Fatma EserFEFatma Eser
- 29 June 2022
- journal article
- research article
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 14 (2) , 386-390
Abstract
Amaç: COVID-19’da şiddetli hastalığı erken tanımak önemlidir. Monosit / yüksek dansiteli lipoprotein oranı (MHR), inflamasyon seyrini belirlemede kullanılan yeni bir belirteçtir. Bu çalışmada MHR ile COVID-19 seyri arasındaki ilişkiyi incelemek amaçlanmıştır. Materyal ve Metod: Laboratuvar ile konfirme edilmiş COVID-19 hastaları retrospektif olarak analiz edildi. Hastanemize başvuran hastanın ilk günki klinik semptomları, bulguları, ve laboratuvar sonuçları hastane bilgi işlem sisteminden taranarak kayıt altına alındı. Çalışmamıza toplam 301 hasta dahil edildi. Hastalar Dünya Sağlık Örgütü (DSÖ) klavuzu dikkate alınarak sınıflandırıldı. MHR hastaların hastaneye kabul edildiği ilk gün bakılan laboratuvar verileri kullanılarak hesaplandı. MHR ile COVID-19 şiddeti arasındaki ilişki değerlendirildi. Hasta verileri SPSS 25 (SPSS Inc., Chicago, IL, USA) kullanılarak analiz edildi. İstatistiksel olarak P<0.05 olan farklılıklar anlamlı kabul edildi. Bulgular: Hastaların 196 (%65,1)’sı hafif ve orta semptomlu COVID-19 iken, 105 (%34,9)’i şiddetli COVID-19 idi. Çalışmamızda şiddetli COVID-19 hastalarında yaş ortalamasının daha yüksek olduğu ve komorbid hastalıkların daha sık görüldüğü bulunmuştur. Çalışmamızda grublar arasında monosit sayısında anlamlı fark izlenmez iken, şiddetli COVID-19 hasta grubunda MHR anlamlı olarak daha yüksek saptanmıştır. Sonuç: COVID-19’da gerçekleşen sitokin fırtınasında monositler önemli rol üstlenir. Gelişen inflamasyon nedeni ile hastalarda dislipidemi izlenir. MHR COVID-19’da inflamatuar biyobelirteç olarak kullanılabilir. Objective: Early diagnosis is important for severe diseases in COVID-19. Monocyte/high dansity lipoprotein ratio (MHR) is a new prognostic marker indicating inflammation. We aimed to investigate the relationship between MHR and diseases severity in COVID-19. Materials and Methods: Patients with laboratory confirmed COVID-19, were retrospectively analyzed. Clinical symptoms, signs and laboratory data on the first day of hospitalization were obtained from medical records of hospital. The clinical data of 301 patients were included in study. Cases were diagnosed on the basis of interim guidance of World Health Organization (WHO). Patients were classified into two groups as non-severe COVID-19 and severe COVID-19. MHR were calculated with laboratory data on the first day of hospitalization. The relationship between MHR level and COVID-19 severity was evaluated. Statistical analysis of the data was performed by using SPSS 25 (SPSS Inc., Chicago, IL, USA) package program. Statistical significance level was accepted as p<0.05. Results: One hundred ninety-six patients (65.1 %) had non-severe COVID-19,105 patients (34.9 %) had severe COVID-19. In our study, it was found that the mean age was higher in severe patients and comorbid diseases were more common. Although monocyte count values were not statistically significantly different, MHR was significantly higher in severe COVID-19 than non-severe COVID-19. Conclusions: Monocytes are very important to cytokine storm in COVID-19. Dyslipidemia can occur in viral infection because of inflammation. MHR can be used as an inflammatory marker in COVID-19.Keywords
This publication has 26 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- More Than Pneumonia, The Potential Occurrence of Multiple Organ Failure in 2019 Novel Coronavirus InfectionSSRN Electronic Journal, 2020
- A New Inflammatory Marker: Elevated Monocyte to HDL Cholesterol Ratio Associated with SmokingJournal of Clinical Medicine, 2018
- Lipid Abnormalities and Inflammation in HIV InflectionCurrent HIV/AIDS Reports, 2016
- Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic InflammationClinical and Applied Thrombosis/Hemostasis, 2015
- Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular DomainsPLOS Pathogens, 2009